tranexamic acid has been researched along with Lacrimal Duct Obstruction in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Lacrimal Duct Obstruction: Interference with the secretion of tears by the lacrimal glands. Obstruction of the LACRIMAL SAC or NASOLACRIMAL DUCT causing acute or chronic inflammation of the lacrimal sac (DACRYOCYSTITIS). It is caused also in infants by failure of the nasolacrimal duct to open into the inferior meatus and occurs about the third week of life. In adults occlusion may occur spontaneously or after injury or nasal disease. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p250)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alam, MS | 1 |
| Barh, A | 1 |
| Kundu, D | 1 |
1 trial available for tranexamic acid and Lacrimal Duct Obstruction
| Article | Year |
|---|---|
A randomized control trial on the role of tranexamic acid in preventing intraoperative bleeding during external dacryocystorhinostomy.
Topics: Blood Loss, Surgical; Dacryocystorhinostomy; Double-Blind Method; Female; Humans; Lacrimal Duct Obst | 2022 |